Security key
881624209
TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (TEVA)
CUSIP: 881624209
Q2 2023 13F Holders as of 30 Jun 2023
- Security type / class
- Equity / Ordinary Shares, par value NIS 0.01 per share
- Total 13F shares
- 494,500,315
- Total 13F value
- $3,725,733,619
- Share change
- -65,417,267
- Put/Call ratio
- 76%
- SEC-reported price per share
- $7.53
- Number of holders
- 415
- Value change
- -$615,772,920
- Number of buys
- 171
- Number of sells
- 196
- Shares outstanding
- 1,148,777,709
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2023
Institutions
415
Top holders
10
TEVA full security history
Ownership snapshot
Full 13F holder table
TEVA PHARMACEUTICAL INDUSTRIES LTD SEC filings
TEVA PHARMACEUTICAL INDUSTRIES LTD company facts
Broader feeds
Ownership snapshot
Top reported holders of TEVA - TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Capital Research Global I...
Disclosed value leader
Capital Research Global I...
Comparable rows
15/15
Latest evidence
31 Mar 2023
13F
Lead comparable stake: 7.2%
Showing 1-6 of 15 holder rows.
Quick read
Capital Research Global Investors leads the comparable SEC ownership view at 7.2%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Capital Research Global Investors's linked filing trail.
Comparable ownership
Top 5
Capital Research Global Investors
7.2%
Capital World Investors
4.4%
BlackRock Finance, Inc.
3.5%
Ion Asset Management Ltd.
2.5%
MENORA MIVTACHIM HOLDINGS LTD.
2.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Capital Research Global Investors |
13F
Company
|
7.2%
|
$731,402,122
82,644,367 shares
|
— | 31 Mar 2023 |
| Capital World Investors |
13F
Company
|
4.4%
|
$448,156,593
50,639,163 shares
|
— | 31 Mar 2023 |
| BlackRock Finance, Inc. |
13F
Company
|
3.5%
|
$355,472,473
40,166,381 shares
|
— | 31 Mar 2023 |
| Ion Asset Management Ltd. |
13F
Company
|
2.5%
|
$249,488,000
28,190,724 shares
|
— | 31 Mar 2023 |
| MENORA MIVTACHIM HOLDINGS LTD. |
13F
Company
|
2.3%
|
$235,774,779
26,641,218 shares
|
— | 31 Mar 2023 |
| Migdal Insurance & Financial Holdings Ltd. |
13F
Company
|
2%
|
$206,617,000
23,346,560 shares
|
— | 31 Mar 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
415
Shares
494,500,315
Rows available
415
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
431
Q2 2023 holders
415
Holder diff
-16
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 value | Q2 2023 value | Value change | Value Chg % |
|---|